# We’re raising our price target on Cardinal Health after another stellar quarter of profits

- URL: https://talkfuse.com/story/were-raising-our-price-target-on-cardinal-health-after-another-stellar-quarter-of-profits/
- Published: 2026-11-05T16:51:58+00:00
- Updated: 2026-11-05T17:53:57+00:00
- Original publisher: CNBC (publisher lean: Centre)
- Original article: https://www.cnbc.com/investingclub/2026/11/05/were-raising-our-price-target-on-cardinal-health-after-another-stellar-quarter-of-profits.html
- Topics: Business, Companies, Health, Medicine

## Key points

- Cardinal Health beat first-quarter revenue and earnings forecasts.
- Adjusted earnings per share rose 28% to $3.26.
- The company raised its full-year earnings outlook.

## Summary

Cardinal Health reported a stronger-than-expected start to fiscal 2027 and raised its full-year earnings outlook, reinforcing its position as a defensive healthcare stock. Its largest business returned to beating sales and profit expectations, while the results came amid investor interest in companies less tied to the AI boom.

Revenue was $67.51 billion, up 4% year on year and above the $66.6 billion consensus; adjusted earnings per share rose 28% to $3.26, versus expectations of $2.94. Pharmaceutical and Specialty Solutions benefited from demand for generic medicines and specialty treatments, with specialty sales growing at a high-teens rate. The smaller Other segment missed revenue and operating profit expectations.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.